Author:
Cattaneo Giulia Maria,Varotto-Boccazzi Ilaria,Molteni Riccardo,Ronchetti Federico,Gabrieli Paolo,Mendoza-Roldan Jairo Alfonso,Otranto Domenico,Montomoli Emanuele,Bandi Claudio,Epis Sara
Abstract
AbstractThe development of media for cell culture is a major issue in the biopharmaceutical industry, for the production of therapeutics, immune-modulating molecules and protein antigens. Chemically defined media offer several advantages, as they are free of animal-derived components and guarantee high purity and a consistency in their composition. Microorganisms of the genus Leishmania represent a promising cellular platform for production of recombinant proteins, but their maintenance requires supplements of animal origin, such as hemin and fetal bovine serum. In the present study, three chemically defined media were assayed for culturing Leishmania tarentolae, using both a wild-type strain and a strain engineered to produce a viral antigen. Among the three media, Schneider's Drosophila Medium supplemented with Horseradish Peroxidase proved to be effective for the maintenance of L. tarentolae promastigotes, also allowing the heterologous protein production by the engineered strain. Finally, the engineered strain was maintained in culture up to the 12th week without antibiotic, revealing its capability to produce the recombinant protein in the absence of selective pressure.
Funder
Fondazione Romeo ed Enrica Invernizzi
Erogazione liberale per le attività di ricerca sul Coronavirus
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Klatt, S., Simpson, L., Maslov, D. A. & Konthur, Z. Leishmania tarentolae: Taxonomic classification and its application as a promising biotechnological expression host. PLoS Negl. Trop. 13(7), e0007424. https://doi.org/10.1371/journal.pntd.0007424 (2019).
2. de Oliveira, T. A. et al. Application of the LEXSY Leishmania tarentolae system as a recombinant protein expression platform: A review. Process Biochem. 87, 164–173. https://doi.org/10.1016/j.procbio.2019.08.019 (2019).
3. Bandi, C. et al. Leishmania tarentolae: A vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections. Parasit. Vectors. 16(1), 35. https://doi.org/10.1186/s13071-023-05651-1 (2023).
4. Bahrami, S., Hatam, G. R., Razavi, M. & Nazifi, S. In vitro cultivation of axenic amastigotes and the comparison of antioxidant enzymes at different stages of Leishmania tropica. Trop. Biomed. 28(2), 411–417 (2011).
5. Aydogdu, M. et al. Large-scale cultivation of Leishmania infantum promastigotes in stirred bioreactor. J. Vector Borne Dis. 56(4), 345–350. https://doi.org/10.4103/0972-9062.302038 (2019).